Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Tomasz Sacha Jorge Eduardo Cortes |
| Publication date | December 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |